BSEBoard MeetingResults6 Aug 2026
Accuracy Shipping Ltd
Accuracy Shipping Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Accuracy Shipping Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider and approve unaudited financial results for the quarter ended June 30, 2026.
BSEBoard MeetingResults6 Aug 2026
Network People Services Technologies Ltd
Network People Services Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Pursuant ....
Network People Services Technologies Ltd has scheduled a board meeting on August 11, 2026, to consider and approve the un-audited consolidated and standalone financial results for the quarter ended June 30, 2026, and other business.
BSEBoard MeetingResults6 Aug 2026
Vijaya Diagnostic Centre Ltd
The Board of Directors in their meeting held on August 6, 2026 have approved the financial results for the quarter ended June 30, 2026
Vijaya Diagnostic Centre Ltd has approved its financial results for the quarter ended June 30, 2026.
BSECompany UpdateResults6 Aug 2026
Innova Captab Ltd
Pursuant to regulation 29 of the Securities Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015, we hereby inform you that the meeting of the Board ....
Innova Captab Ltd has scheduled a Board meeting on 11th August 2026 to consider and approve the unaudited financial results for the quarter ended 30th June 2026 and the revised audited financial results for the quarter and financial year ended 31st March 2026.
BSECompany UpdateResults6 Aug 2026
Signatureglobal (India) Ltd
Audio Recording of the Q1 FY27 Earnings Conference Call
Signatureglobal (India) Ltd has made available the audio recording of its Q1 FY27 earnings conference call on its website.
BSEBoard MeetingResults6 Aug 2026
GSS Infotech Ltd
GSS Infotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve financial results for the first ....
GSS Infotech Ltd has scheduled a Board Meeting on 14/08/2026 to consider and approve financial results for the first quarter ended June 30, 2026, and other business matters.
BSEAGM/EGMResults6 Aug 2026
Virat Industries Ltd
Please find attached proceedings of 36th Annual General Meeting held today i.e. 6th August, 2026.
Virat Industries Ltd held its 36th Annual General Meeting (AGM) on August 6, 2026, through video conferencing. The meeting was attended by 28 members, and the necessary resolutions were passed, including the adoption of audited financial statements for the year ended March 31, 2026.
BSECompany UpdateResults6 Aug 2026
Paisalo Digital Ltd
Intimation regarding publication of financial results for q1 2026-27
Paisalo Digital Ltd has announced the publication of its Q1 2026-27 financial results in newspapers, as approved by the Board of Directors on August 5, 2026.
BSEBoard MeetingResults6 Aug 2026
Parvati Sweetners and Power Ltd
Parvati Sweetners And Power Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve 1.Approval of the ....
Parvati Sweetners and Power Ltd has scheduled a board meeting on 12th August 2026 to consider and approve the unaudited quarterly financial results for the quarter ended 30th June 2026, along with other routine businesses.
BSEResultResults6 Aug 2026
Jenburkt Pharmaceuticals Ltd
Standalone Unaudited Financial Results for the quarter ended on 30th June, 2026.
Jenburkt Pharmaceuticals Ltd has announced its standalone unaudited financial results for the quarter ended on 30th June, 2026, with a profit before tax of Rs. 676.91 crores and a net profit of Rs. 588.56 crores.
BSECompany Update▲ PositiveResults6 Aug 2026
Crompton Greaves Consumer Electricals Ltd
Press Release
Crompton Greaves Consumer Electricals Ltd. reported its standalone & consolidated financials for the quarter ended 30th June 2026, with consolidated revenue growth of 11.8% YoY, EBITDA growth of 14.2%, and PAT growth of 15.2% YoY.
BSEBoard MeetingResults6 Aug 2026
AKI India Ltd
AKI India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting to be ....
AKI India Ltd has informed BSE that a meeting of the Board of Directors is scheduled on 11/08/2026 to consider unaudited standalone and consolidated financial results for the quarter ended 30/06/2026.
BSEBoard MeetingResults6 Aug 2026
Jenburkt Pharmaceuticals Ltd
Outcome of the Board Meeting held today on 06th August, 2026.
Jenburkt Pharmaceuticals Ltd has announced its standalone unaudited financial results for the quarter ended 30 June 2026, with revenue from operations at Rs 3551.20 crore and profit after tax at Rs 588.56 crore.
BSECompany UpdateResults6 Aug 2026
Chemplast Sanmar Ltd
Investor Presentation
Chemplast Sanmar Ltd has released its Q1 FY '27 investor presentation, highlighting revenue growth in its speciality segment, particularly in the paste PVC segment, and a healthy revenue run-rate in its custom manufactured chemicals division. However, the commodity segment was impacted by market headwinds, declining prices, and reduced sales volumes. The company also reported a fire incident in Karaikal, but no injuries or spillages were reported.
BSEBoard MeetingResults6 Aug 2026
Abans Enterprises Ltd
Abans Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
Abans Enterprises Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 11/08/2026 to consider and approve Unaudited Financial Results for the quarter ended June 30, 2026.
BSEBoard MeetingResults6 Aug 2026
Om Power Transmission Ltd
Om Power Transmission Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve financial results for ....
Om Power Transmission Ltd has scheduled a Board Meeting on August 11, 2026, to consider and approve the Unaudited Financial Results for the Quarter ended June 30, 2026.
BSECompany Update▲ PositiveResults6 Aug 2026
Wakefit Innovations Ltd
Press release in relation to the unaudited financial results for the quarter ended June 30, 2026
Wakefit Innovations Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations increasing by 16.6% YoY to INR 4,049.1 million, and reported EBITDA (excluding Other Income) increasing to INR 564.0 million, with an EBITDA margin of 13.9%. Profit Before Tax rose to INR 363.1 million, an increase of 85.1% YoY, while Profit After Tax for the quarter stood at INR 233.8 million, registering a YoY increase of 19.2%. The company has also added 27 new stores during the quarter, taking the total active COCO stores to 165.
BSECompany UpdateResults6 Aug 2026
Anlon Healthcare Ltd
We have attached herewith intimation as per Reg. 30 of SEBI (LODR) Regulation, 2015.
Kindly take the same on your record.
Thank you.
Anlon Healthcare Ltd has announced the availability of the audio recording of its Q1/FY-27 earnings conference call on its website.
BSEBoard MeetingResults6 Aug 2026
Confidence Futuristic Energetech Ltd
attaching herewith outcome of Board meeting
Confidence Futuristic Energetech Ltd has announced its unaudited financial results for the first quarter ended June 30, 2026, with revenue from operations at Rs 1,640.00 lacs and profit before tax at Rs 2,295.32 lacs. The company's consolidated revenue from operations stood at Rs 3,583.98 lacs and profit before tax at Rs 1,173.19 lacs.
BSECompany Update▲ PositiveResults6 Aug 2026
GlaxoSmithKline Pharmaceuticals Ltd
Transcript
GlaxoSmithKline Pharmaceuticals Ltd announced its Q1 FY 2027 earnings call, with Managing Director Mr. Bhushan Akshikar and Chief Financial Officer Mr. Rononjit Biswas presenting the results. The company reported a 13.5% industry growth, with a balanced mix of volume, price, and new introductions. GlaxoSmithKline's portfolio showed a significant presence in therapy areas such as anti-infectives, pain, respiratory, nutritional supplements, vitamins, dermatologicals, and hormones and vaccines, which all grew double-digit. The company's growth was balanced across geographies, including metros, Tier 1 cities, Tier 2 and rural markets, and among specialists, super specialists, and general practitioners.